Perspective
Feb. 16, 2012
Justices consider patent process for personalized medicine industry
The patent process, as it stands, is impeding innovation in the personalized medicine industry. By Michael J. Shuster of Fenwick & West LLP
In the past decade, personalized medicine has emerged as one of the most promising areas of medical research. It holds great potential for improving patient outcomes and reducing human suffering as well as driving down health care costs.
But innovation needs to be nurtured. In the U.S., the primary mechanism to incentivize innovation is the patent process. The Constitution states that Congress shall have the power to "promote ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In